FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
Understanding the link between weight and arthritis pain could be key to finding relief. Learn how small changes in lifestyle can make a big difference.
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
The traditional Chinese practice of qigong can effectively alleviate chronic low back pain (CLBP), according to a study ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
Samaritan Medical Center is closing its Pain Management Center at the end of February because it’s “not meeting the ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.